Hemoglobin and Iron Metabolism Practice Questions

Q: Heme is synthesized in which part of the erythroblastic cells?

Mitochondrial matrix. ### Explanation **Correct Option: D. Mitochondrial matrix** Heme synthesis is a complex metabolic pathway that occurs primarily in the **erythroblastic cells** of the bone marrow (85%) and the hepatocytes of the liver. The process is unique because it is compartmentalized between the **mitochondria** and the **cytosol**. * **The Mitochondrial Phase:** The first step (condensation of Succinyl CoA and Glycine to form δ-ALA by the enzyme ALA synthase) and the final three steps (leading to the formation of Protoporphyrin IX and the insertion of ferrous iron by **Ferrochelatase**) occur within the **mitochondrial matrix** and inner membrane. * **The Cytosolic Phase:** The intermediate steps, starting from the formation of Porphobilinogen (PBG) up to Coproporphyrinogen III, occur in the cytosol. Since the final assembly of the heme ring and the incorporation of iron happen inside the mitochondria, it is considered the primary site of synthesis. **Why other options are incorrect:** * **A. Golgi complex:** Responsible for protein packaging and post-translational modification, not heme synthesis. * **B. Ribosomes:** The site of globin chain synthesis (protein part of hemoglobin), but not the heme (prosthetic group) part. * **C. Endoplasmic reticulum:** Involved in lipid synthesis and protein folding; while the Cytochrome P450 system (which contains heme) is located here, the heme itself is synthesized in the mitochondria. --- ### High-Yield Clinical Pearls for NEET-PG 1. **Rate-limiting enzyme:** ALA Synthase (requires **Vitamin B6/Pyridoxine** as a cofactor). Deficiency can lead to Sideroblastic Anemia. 2. **Lead Poisoning:** Inhibits two enzymes in this pathway—**ALA Dehydratase** and **Ferrochelatase**. 3. **Mature RBCs:** Cannot synthesize heme because they lack mitochondria. 4. **Heme vs. Hemin:** Heme contains $Fe^{2+}$ (Ferrous), while Hemin contains $Fe^{3+}$ (Ferric).

Q: Hepcidin is associated with which molecule?

Iron. **Explanation:** **Hepcidin** is the master regulator of iron homeostasis in the human body. It is a peptide hormone synthesized primarily by the **liver** in response to high iron levels or inflammatory cytokines (like IL-6). **Why Iron is the Correct Answer:** Hepcidin controls iron levels by binding to **Ferroportin**, the only known cellular iron exporter found on the surface of enterocytes, macrophages, and hepatocytes. When Hepcidin binds to Ferroportin, it induces its internalization and degradation. This results in: 1. **Decreased intestinal iron absorption** (iron stays trapped in enterocytes). 2. **Decreased iron release** from macrophages (recycling of senescent RBCs). Consequently, high Hepcidin levels lead to low serum iron, while Hepcidin deficiency leads to iron overload (e.g., Hemochromatosis). **Why Other Options are Incorrect:** * **Copper:** Regulated primarily by **Ceruloplasmin** (transport) and **ATP7B** (excretion). Deficiency leads to Menkes disease; toxicity leads to Wilson disease. * **Selenium:** A cofactor for **Glutathione Peroxidase**. It is not regulated by Hepcidin. * **Fluorine:** Primarily involved in dental and bone health (fluoroapatite formation). It is not linked to Hepcidin. **High-Yield Clinical Pearls for NEET-PG:** * **Anemia of Chronic Disease (ACD):** Inflammatory states (IL-6) increase Hepcidin, causing iron to be "locked" in macrophages. This leads to low serum iron despite normal/high ferritin. * **Hereditary Hemochromatosis:** Most commonly caused by mutations in the **HFE gene**, leading to inappropriately low Hepcidin levels and systemic iron overload. * **Stimuli:** Hepcidin is **increased** by iron overload and inflammation; it is **decreased** by hypoxia and increased erythropoietic activity.

Q: 2,3 DPG binds to __________ site of Hb and __________ release of O2

One, increase. **Explanation:** **1. Why Option A is Correct:** 2,3-Bisphosphoglycerate (2,3-DPG) is a highly anionic molecule that binds to a **single** central cavity (one site) located between the two beta-globin chains of the hemoglobin tetramer. This binding occurs specifically in the **T-state (Tense state)** or deoxygenated form. 2,3-DPG stabilizes the T-state by forming salt bridges, which reduces hemoglobin's affinity for oxygen. This shifts the oxygen-dissociation curve to the **right**, thereby **increasing the release of O2** to the peripheral tissues. **2. Why Other Options are Incorrect:** * **Options B & D (Four sites):** Hemoglobin has four binding sites for oxygen (one per heme group), but it only has **one** regulatory binding site for 2,3-DPG. * **Options C & D (Decrease release):** Decreasing the release of O2 would mean an increase in O2 affinity (Left shift). 2,3-DPG does the opposite; a decrease in 2,3-DPG (as seen in stored blood) would decrease O2 release. **3. Clinical Pearls for NEET-PG:** * **Fetal Hemoglobin (HbF):** HbF has a lower affinity for 2,3-DPG because its gamma chains have **serine** instead of histidine at position 143. This results in a higher O2 affinity, allowing the fetus to "pull" oxygen from maternal blood. * **Adaptation to Altitude:** Chronic hypoxia at high altitudes leads to an **increase** in 2,3-DPG levels to facilitate better oxygen unloading at tissues. * **Stored Blood:** Levels of 2,3-DPG drop in stored blood. Transfusing large amounts of "old" blood can temporarily impair oxygen delivery to tissues until the recipient's body regenerates 2,3-DPG.

Q: One mole of myoglobin binds to how many moles of oxygen?

1. ### Explanation **Correct Option: A (1)** Myoglobin is a monomeric hemeprotein found primarily in skeletal and cardiac muscle. Structurally, it consists of a single polypeptide chain (globin) associated with a single heme group. Since one heme group contains one ferrous iron ($Fe^{2+}$) atom capable of binding to one molecule of oxygen ($O_2$), **one mole of myoglobin binds to exactly one mole of oxygen.** **Analysis of Incorrect Options:** * **Option B (2):** This is incorrect as there is no physiological hemoglobin or myoglobin variant that binds specifically to two moles of oxygen per mole of protein. * **Option C (4):** This describes **Hemoglobin (HbA)**. Hemoglobin is a tetramer consisting of four polypeptide chains, each with its own heme group. Therefore, one mole of hemoglobin binds to four moles of oxygen. **High-Yield Clinical Pearls for NEET-PG:** * **Oxygen Dissociation Curve (ODC):** Myoglobin exhibits a **hyperbolic** ODC, reflecting its high affinity for oxygen even at low partial pressures. In contrast, Hemoglobin exhibits a **sigmoidal** curve due to cooperativity. * **Function:** Myoglobin acts as an oxygen storage unit in muscles, releasing $O_2$ only during severe hypoxia or intense muscular contraction. It does not show the Bohr effect or sensitivity to 2,3-BPG. * **Clinical Marker:** Myoglobin is the **earliest cardiac marker** to rise following a Myocardial Infarction (within 1–3 hours), though it is not specific to cardiac muscle. * **Renal Impact:** In rhabdomyolysis, massive release of myoglobin into the blood (myoglobinuria) can lead to acute tubular necrosis and renal failure.

Q: What is the most common type of Porphyria?

Porphyria cutanea tarda. **Explanation:** **Porphyria Cutanea Tarda (PCT)** is the most common type of porphyria worldwide. It results from a deficiency of the enzyme **Uroporphyrinogen decarboxylase (UROD)**. Unlike many other porphyrias, PCT is unique because it is most frequently **acquired (Type I)**, often triggered by factors like alcohol consumption, Hepatitis C, smoking, or iron overload, though a familial form (Type II) also exists. Clinically, it presents with photosensitivity and fluid-filled blisters on sun-exposed areas (hands and face). **Analysis of Incorrect Options:** * **Acute Intermittent Porphyria (AIP):** This is the most common **acute** (neurovisceral) porphyria, but not the most common overall. It is caused by a deficiency of Porphobilinogen deaminase. * **Variegate Porphyria:** This is a mixed porphyria (cutaneous and neurological symptoms) caused by Protoporphyrinogen oxidase deficiency. It is rare globally but has a high prevalence in South Africa due to a founder effect. * **Congenital Erythropoietic Porphyria (Gunther disease):** An extremely rare autosomal recessive disorder caused by Uroporphyrinogen III synthase deficiency, characterized by severe mutilating photosensitivity and erythrodontia (red teeth). **High-Yield Clinical Pearls for NEET-PG:** * **Enzyme Defect in PCT:** Uroporphyrinogen decarboxylase. * **Urine Finding:** Urine shows "tea-colored" or "port-wine" discoloration and fluoresces **coral pink** under Wood’s lamp due to uroporphyrins. * **Key Association:** Strongly associated with **Hepatitis C** and **Iron Overload** (Hereditary Hemochromatosis). * **Treatment:** Low-dose chloroquine/hydroxychloroquine or therapeutic phlebotomy to reduce iron stores.

Q: Bioavailability of non-heme iron is low compared to heme iron because:

Phytates inhibit absorption.. ### Explanation **1. Why the Correct Answer is Right:** Iron exists in two dietary forms: **Heme iron** (found in animal sources like meat) and **Non-heme iron** (found in plant sources like cereals and legumes). Heme iron is absorbed intact via specific transporters (HCP-1) and is highly bioavailable (15–35%). In contrast, non-heme iron (mostly in the ferric $Fe^{3+}$ state) must be reduced to the ferrous $Fe^{2+}$ state to be absorbed via DMT-1. The bioavailability of non-heme iron is significantly lower (2–20%) because it is highly sensitive to **dietary inhibitors**. **Phytates** (found in whole grains and nuts), **oxalates**, **polyphenols/tannins** (in tea/coffee), and **phosphates** bind to non-heme iron in the alkaline environment of the small intestine, forming insoluble complexes that cannot be absorbed. **2. Analysis of Incorrect Options:** * **Option A (Micronutrients):** While some micronutrients (like Copper) are essential for iron metabolism (e.g., Ceruloplasmin), they do not explain the *low* bioavailability compared to heme iron. * **Option C & D (Acids and Vitamin C):** These actually **increase** non-heme iron absorption. Gastric acid and Vitamin C (Ascorbic acid) act as reducing agents, converting $Fe^{3+}$ to $Fe^{2+}$ and maintaining its solubility. Therefore, they improve bioavailability rather than lowering it. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Meat Factor":** Small amounts of meat can enhance the absorption of non-heme iron when consumed together. * **Hepcidin:** The master regulator of iron; it degrades Ferroportin, thereby decreasing iron release into the plasma. * **Storage:** Iron is stored as **Ferritin** (soluble) and **Hemosiderin** (insoluble). * **Transport:** Iron is transported in the blood by **Transferrin** in the $Fe^{3+}$ state.

Q: Which of the following proteins possesses ferroxidase activity?

Ceruloplasmin. **Explanation:** **Ceruloplasmin** is the correct answer because it is a copper-containing α2-globulin that functions as a **ferroxidase enzyme**. In iron metabolism, iron is absorbed or released from stores in the ferrous state ($Fe^{2+}$). However, to be loaded onto its transport protein, transferrin, it must be oxidized to the ferric state ($Fe^{3+}$). Ceruloplasmin catalyzes this $Fe^{2+} \rightarrow Fe^{3+}$ conversion, facilitating iron transport and preventing the formation of toxic free radicals. **Analysis of Incorrect Options:** * **Albumin (A):** The most abundant plasma protein; it functions primarily in maintaining oncotic pressure and transporting various ligands (bilirubin, fatty acids, drugs), but lacks enzymatic ferroxidase activity. * **Haptoglobin (C):** An acute-phase reactant that binds **free hemoglobin** released during intravascular hemolysis to prevent iron loss via kidneys and protect against oxidative damage. * **Transferrin (D):** The primary **transport protein** for iron in the blood. It binds iron only in the ferric ($Fe^{3+}$) state but does not perform the oxidation itself. **High-Yield Clinical Pearls for NEET-PG:** * **Wilson’s Disease:** Characterized by a deficiency of ceruloplasmin due to defective copper incorporation and biliary excretion. Low serum ceruloplasmin is a key diagnostic marker. * **Hephaestin:** A homologous ferroxidase found on the basolateral membrane of enterocytes that works with ferroportin to export iron into the blood. * **Ferroxidase Deficiency:** Leads to iron accumulation in tissues (hemosiderosis) because iron cannot be mobilized from storage sites (macrophages/liver) onto transferrin.

Q: Iron is present in all of the following compounds except:

Pyruvate Kinase. **Explanation:** The correct answer is **Pyruvate Kinase**. Iron is a vital trace element primarily found in the body as part of **Heme-containing proteins** or **Iron-sulfur (Fe-S) cluster proteins**. **1. Why Pyruvate Kinase is the correct answer:** Pyruvate Kinase is a key glycolytic enzyme that catalyzes the conversion of phosphoenolpyruvate (PEP) to pyruvate. Unlike heme-enzymes, Pyruvate Kinase requires **Potassium (K⁺)** and **Magnesium (Mg²⁺)** (or Manganese) as cofactors for its catalytic activity. It does not contain iron in its structure. **2. Analysis of incorrect options:** * **Myoglobin:** This is a monomeric heme protein found in muscle tissue. It contains a single heme group with an iron atom in the ferrous ($Fe^{2+}$) state, responsible for oxygen storage. * **Cytochromes:** These are heme-containing proteins (e.g., Cytochrome c, Cytochrome P450) essential for the Electron Transport Chain (ETC) and drug metabolism. They utilize the reversible oxidation-reduction of iron ($Fe^{2+} \leftrightarrow Fe^{3+}$) to transport electrons. * **Catalase:** This is a major antioxidant enzyme that protects cells from oxidative damage by decomposing hydrogen peroxide. It is a tetrameric protein containing four heme groups with central iron atoms. **High-Yield Clinical Pearls for NEET-PG:** * **Heme-containing enzymes:** Hemoglobin, Myoglobin, Cytochromes, Catalase, Peroxidase, and Tryptophan pyrrolase. * **Non-heme iron proteins:** Ferritin (storage), Transferrin (transport), and Succinate dehydrogenase (Fe-S cluster). * **Pyruvate Kinase Deficiency:** The most common enzyme deficiency in the glycolytic pathway, leading to **Chronic Non-spherocytic Hemolytic Anemia** due to ATP depletion in RBCs.

Q: What is the half-life of the haptoglobin complex?

10 minutes. **Explanation:** **Haptoglobin** is an acute-phase reactant protein synthesized by the liver. Its primary physiological role is to bind free hemoglobin (Hb) released into the plasma during intravascular hemolysis. 1. **Why 10 minutes is correct:** While free haptoglobin has a circulating half-life of approximately **5 days**, the **Haptoglobin-Hemoglobin (Hp-Hb) complex** is cleared extremely rapidly from the circulation. Once the complex forms, it is recognized by **CD163 receptors** on macrophages (primarily in the spleen and liver). This receptor-mediated endocytosis is highly efficient, resulting in a half-life of about **10 to 20 minutes**. This rapid clearance prevents hemoglobin-induced oxidative tissue damage and prevents the loss of iron through the kidneys (preventing hemoglobinuria). 2. **Why other options are incorrect:** * **5 days (Option A):** This is the half-life of **unbound (free) haptoglobin**. In states of hemolysis, haptoglobin levels drop to near zero because it is consumed faster than it is produced. * **3 days / 10 days (Options B & C):** These values do not correspond to haptoglobin kinetics. Most plasma proteins have half-lives measured in days, but the Hp-Hb complex is a notable exception due to its rapid "suicide" clearance mechanism. **High-Yield Clinical Pearls for NEET-PG:** * **Marker of Hemolysis:** A **decreased serum haptoglobin level** is the most sensitive laboratory indicator of **intravascular hemolysis**. * **Size Exclusion:** The Hp-Hb complex is too large to be filtered by the renal glomeruli; thus, haptoglobin protects the kidneys from iron-mediated tubular damage. * **Acute Phase Reactant:** Haptoglobin levels may be falsely normal or elevated during inflammation, even if hemolysis is present. * **Hemopexin:** If haptoglobin is saturated, free heme is bound by **Hemopexin**. If that is also saturated, heme binds to albumin to form **methemalbumin**.

Question 1

Heme is synthesized in which part of the erythroblastic cells?

Accepted Answer

Mitochondrial matrix

Answer

Golgi complex

Answer

Ribosomes

Answer

Endoplasmic reticulum

Question 2

Hepcidin is associated with which molecule?

Accepted Answer

Iron

Answer

Copper

Answer

Selenium

Answer

Fluorine

Question 3

2,3 DPG binds to __________ site of Hb and __________ release of O2

Accepted Answer

One, increase

Answer

Four, increase

Answer

One, decrease

Answer

Four, decrease

Question 4

One mole of myoglobin binds to how many moles of oxygen?

Accepted Answer

1

Answer

2

Answer

4

Answer

None of the above

Question 5

What is the most common type of Porphyria?

Accepted Answer

Porphyria cutanea tarda

Answer

Variegate porphyria

Answer

Congenital erythropoietic porphyria

Answer

Acute intermittent porphyria

Question 6

Bioavailability of non-heme iron is low compared to heme iron because:

Accepted Answer

Phytates inhibit absorption.

Answer

Micronutrients enhance absorption.

Answer

Acids enhance absorption.

Answer

Vitamin C enhances absorption.

Question 7

Which of the following proteins possesses ferroxidase activity?

Accepted Answer

Ceruloplasmin

Answer

Albumin

Answer

Haptoglobin

Answer

Transferrin

Question 8

Iron is present in all of the following compounds except:

Accepted Answer

Pyruvate Kinase

Answer

Myoglobin

Answer

Cytochrome

Answer

Catalase

Question 9

Which of the following features differentiates Rotor syndrome from Dubin-Johnson syndrome?

Accepted Answer

The fraction of coproporphyrin I in urine is elevated, usually more than 80% of the total in Rotor syndrome.

Answer

Liver patients with Rotor syndrome have no increased pigmentation and appear normal.

Answer

In Rotor syndrome, the gallbladder is usually visualized on cholecystography.

Answer

Total urinary coproporphyrin is substantially increased in Rotor syndrome.

Question 10

What is the half-life of the haptoglobin complex?

Accepted Answer

10 minutes

Answer

5 days

Answer

3 days

Answer

10 days

Hemoglobin and Iron Metabolism — MCQs

Hemoglobin and Iron Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?